Clinical Trial News and Research

RSS

Can music therapy improve language development in preterm children by 24 months?

The impact of parent-led, infant-directed singing on language development at 24 months.

21 May 2024

Can a coach-supported mobile health intervention reduce dementia risk?

Whether a coach-supported mHealth intervention can reduce dementia risk factors in high-risk, underserved populations.

21 May 2024

Donepezil fails to enhance cognitive abilities in breast cancer survivors: Phase III trial results

Many breast cancer survivors report cancer-related cognitive impairment following chemotherapy, although prevalence rates and severity vary.

20 May 2024

Dupilumab shows promising results in Phase 3 trial for COPD with type 2 inflammation

Chronic obstructive pulmonary disease patients with type 2 inflammation may soon gain access to a new drug -; dupilumab -; that showed rapid and sustained improvements in patients in a pivotal Phase 3 clinical trial, researchers report in the New England Journal of Medicine.

20 May 2024

Researchers design new regenerative medicine therapy to accelerate diabetic wound repair

Researchers at the Icahn School of Medicine at Mount Sinai have designed a regenerative medicine therapy to speed up diabetic wound repair.

20 May 2024

Breakthrough study shows benefits of diagnosing hidden respiratory diseases

Finding and treating people with undiagnosed asthma or chronic obstructive pulmonary disease (COPD) improved their health and reduced their healthcare visits for respiratory symptoms in the year after diagnosis, according to a world-first clinical trial published in the New England Journal of Medicine.

20 May 2024

Best practices in RF ablation yield excellent outcomes for atrial fibrillation patients

Atrial fibrillation (AF) is the most common form of arrythmia or irregular heartbeat worldwide, impacting millions of people in the U.S. alone.

20 May 2024

Acetaminophen shows potential in preventing acute respiratory distress syndrome, organ injury in sepsis patients

A National Institutes of Health (NIH)-supported clinical trial has found that intravenous acetaminophen reduced sepsis patients' risk of having organ injury or developing acute respiratory distress syndrome, a serious condition that allows fluid to leak into the lungs.

20 May 2024

Insilico and NVIDIA unveil new LLM transformer for solving biological and chemical tasks

In a new paper, researchers from clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine ("Insilico"), in collaboration with NVIDIA, present a new large language model (LLM) transformer for solving biological and chemical tasks called nach0.

20 May 2024

Cancer researchers urged to embrace AI for groundbreaking insights and efficiency

A review in Nature Reviews Cancer emphasizes the necessity for cancer researchers to understand AI's potentials and limitations, detailing its applications and challenges in cancer research to aid non-computational biologists.

20 May 2024

Web-based self-help program proves effective in treating binge eating disorder

Study shows that web-based cognitive behavioral self-help interventions effectively reduce binge eating episodes and improve overall well-being in individuals with binge eating disorder (BED).

19 May 2024

MGH investigators use new drug to save the life of patient with immune thrombotic thrombocytopenic purpura

A team led by investigators from Massachusetts General Hospital, a founding member of the Mass General Brigham healthcare system, used a new drug to save the life of a patient with immune thrombotic thrombocytopenic purpura (iTTP), a rare disorder characterized by uncontrolled clotting throughout the small blood vessels.

17 May 2024

Vaccine candidate spurs elusive type of broadly neutralizing HIV antibodies

An HIV vaccine candidate developed at the Duke Human Vaccine Institute triggered low levels of an elusive type of broadly neutralizing HIV antibodies among a small group of people enrolled in a 2019 clinical trial.

17 May 2024

POSTECH and ImmunoBiome make significant breakthrough in the fight against cancer

A team of POSTECH and ImmunoBiome has made a significant breakthrough in the fight against cancer. Their research, published in the May issue of Nature Immunology (Volume 25, pages790–801,2024), explores a dietary-derived bacterial strain, IMB001.

17 May 2024

Varenicline shows promise in first U.S. trial for e-cigarette cessation

The first U.S. trial of varenicline for e-cigarette cessation shows promising results and warrants larger-scale trials, the researchers say.

17 May 2024

Offering screening options boosts colorectal cancer test rates

The rate of colorectal cancer screenings more than doubled when patients were given a choice between which type of screening they wanted-;a take-home kit or colonoscopy-;compared to those who were only offered the colonoscopy, according to new research led by the Perelman School of Medicine at the University of Pennsylvania.

16 May 2024

Text messages with financial rewards boost weight loss in obese men, study finds

Study found that combining behavioral text messages with financial incentives promotes significant weight loss in obese men, while text messages alone do not.

16 May 2024

Ambulance blood pressure treatment benefits hemorrhagic stroke patients, study finds

Early identification of stroke type could be key to harnessing the benefits of very early in-ambulance blood pressure lowering treatment in patients with suspected acute stroke, according to new research.

16 May 2024

New therapy shows greater weight loss in mice by targeting brain's appetite center

A groundbreaking paper in Nature describes a promising new therapy for obesity that leads to greater weight loss in mice than existing medications.

16 May 2024

CONVINCE trial reveals the effect of long-term colchicine on recurrent stroke and cardiovascular events

In the international CONVINCE trial, presented today (15 May 2024) at the European Stroke Organisation Conference (ESOC) 2024, anti-inflammatory treatment with long-term colchicine did not reduce rates of recurrent stroke and cardiovascular events in patients with non-cardioembolic stroke in the primary intention-to-treat analysis.

16 May 2024

1
2
3
4
...
1058
Next

Clinical Trial News and Research

Can music therapy improve language development in preterm children by 24 months?

Can a coach-supported mobile health intervention reduce dementia risk?

Donepezil fails to enhance cognitive abilities in breast cancer survivors: Phase III trial results

Dupilumab shows promising results in Phase 3 trial for COPD with type 2 inflammation

Researchers design new regenerative medicine therapy to accelerate diabetic wound repair

Breakthrough study shows benefits of diagnosing hidden respiratory diseases

Best practices in RF ablation yield excellent outcomes for atrial fibrillation patients

Acetaminophen shows potential in preventing acute respiratory distress syndrome, organ injury in sepsis patients

Insilico and NVIDIA unveil new LLM transformer for solving biological and chemical tasks

Cancer researchers urged to embrace AI for groundbreaking insights and efficiency

Web-based self-help program proves effective in treating binge eating disorder

MGH investigators use new drug to save the life of patient with immune thrombotic thrombocytopenic purpura

Vaccine candidate spurs elusive type of broadly neutralizing HIV antibodies

POSTECH and ImmunoBiome make significant breakthrough in the fight against cancer

Varenicline shows promise in first U.S. trial for e-cigarette cessation

Offering screening options boosts colorectal cancer test rates

Text messages with financial rewards boost weight loss in obese men, study finds

Ambulance blood pressure treatment benefits hemorrhagic stroke patients, study finds

New therapy shows greater weight loss in mice by targeting brain's appetite center

CONVINCE trial reveals the effect of long-term colchicine on recurrent stroke and cardiovascular events

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News